<DOC>
	<DOC>NCT01011504</DOC>
	<brief_summary>The objective of this study is to determine utilisation patterns in patients receiving Angiox® in participating European centres. Additionally, through the collection of descriptive safety and outcomes data, this study will contribute to the Risk Management strategy for Europe</brief_summary>
	<brief_title>Utilisation of Angiox® in European Practice</brief_title>
	<detailed_description />
	<mesh_term>Angina, Stable</mesh_term>
	<criteria>Eligible for, and receive treatment with Angiox®. Willing and able to provide written informed consent to the use of their data in accordance with relevant local Data Protection laws, policies and regulations Participation in other interventional clinical research studies involving the evaluation of investigational drugs, including Angiox®, or devices at the time of enrolment. Patients not eligible for treatment for Angiox®.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>